Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3085% above fair value
$58.31−0.97 (-1.64%)
Close on Nov 18, 2026Market cap $2.00BP/E 39.7Yield –
Ingevity net income
Net income is the profit left for shareholders after every expense, interest and tax.
Ingevity's net income for the twelve months ending Jun 30, 2026 was $54.00M. For fiscal 2025 it was -$167.10M. The highest annual figure on record is $211.60M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$167.10M | – |
| FY2024 | Dec 31, 2024 | -$430.30M | – |
| FY2023 | Dec 31, 2023 | -$5.40M | -102.6% |
| FY2022 | Dec 31, 2022 | $211.60M | +79.2% |
| FY2021 | Dec 31, 2021 | $118.10M | -34.9% |
| FY2020 | Dec 31, 2020 | $181.40M | -1.3% |
| FY2019 | Dec 31, 2019 | $183.70M | +8.6% |
| FY2018 | Dec 31, 2018 | $169.10M | +33.7% |
| FY2017 | Dec 31, 2017 | $126.50M | +259.4% |
| FY2016 | Dec 31, 2016 | $35.20M | -55.8% |
| FY2015 | Dec 31, 2015 | $79.70M | -38.2% |
| FY2014 | Dec 31, 2014 | $129.00M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $35.30M | – |
| Q1 FY2026 | Mar 31, 2026 | $59.80M | +191.7% |
| Q4 FY2025 | Dec 31, 2025 | -$84.60M | -609.6% |
| Q3 FY2025 | Sep 30, 2025 | $43.50M | – |
| Q2 FY2025 | Jun 30, 2025 | -$146.50M | – |
| Q1 FY2025 | Mar 31, 2025 | $20.50M | – |
| Q4 FY2024 | Dec 31, 2024 | $16.60M | – |
| Q3 FY2024 | Sep 30, 2024 | -$107.20M | -525.4% |
| Q2 FY2024 | Jun 30, 2024 | -$283.70M | -899.2% |
| Q1 FY2024 | Mar 31, 2024 | -$56.00M | -210.5% |
| Q4 FY2023 | Dec 31, 2023 | -$116.80M | -848.7% |
| Q3 FY2023 | Sep 30, 2023 | $25.20M | -66.6% |
| Q2 FY2023 | Jun 30, 2023 | $35.50M | -40.6% |
| Q1 FY2023 | Mar 31, 2023 | $50.70M | -16.6% |
| Q4 FY2022 | Dec 31, 2022 | $15.60M | -46.8% |
| Q3 FY2022 | Sep 30, 2022 | $75.40M | – |
| Q2 FY2022 | Jun 30, 2022 | $59.80M | +35.0% |
| Q1 FY2022 | Mar 31, 2022 | $60.80M | +24.8% |
| Q4 FY2021 | Dec 31, 2021 | $29.30M | -36.3% |
| Q3 FY2021 | Sep 30, 2021 | -$4.20M | -106.0% |
| Q2 FY2021 | Jun 30, 2021 | $44.30M | +119.3% |
| Q1 FY2021 | Mar 31, 2021 | $48.70M | +7.5% |
| Q4 FY2020 | Dec 31, 2020 | $46.00M | +3.8% |
| Q3 FY2020 | Sep 30, 2020 | $69.90M | +16.7% |
| Q2 FY2020 | Jun 30, 2020 | $20.20M | -64.4% |
| Q1 FY2020 | Mar 31, 2020 | $45.30M | +99.6% |
| Q4 FY2019 | Dec 31, 2019 | $44.30M | +5.2% |
| Q3 FY2019 | Sep 30, 2019 | $59.90M | +21.0% |
| Q2 FY2019 | Jun 30, 2019 | $56.80M | +21.6% |
| Q1 FY2019 | Mar 31, 2019 | $22.70M | -26.3% |
| Q4 FY2018 | Dec 31, 2018 | $42.10M | +1.2% |
| Q3 FY2018 | Sep 30, 2018 | $49.50M | +46.4% |
| Q2 FY2018 | Jun 30, 2018 | $46.70M | +45.5% |
| Q1 FY2018 | Mar 31, 2018 | $30.80M | +62.1% |
| Q4 FY2017 | Dec 31, 2017 | $41.60M | +357.1% |
| Q3 FY2017 | Sep 30, 2017 | $33.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $32.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $19.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.10M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.20M | – |
See a number that looks wrong?